Patent Law Weblog
recent posts
- Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
about
Category: International IP
-
By Sarah Fendrick — On November 23, 2009, the U.S. Patent and Trademark Office and India's Department of Industrial Policy and Promotion (DIPP) announced the signing of a Memorandum of Understanding (MOU) regarding comprehensive bilateral cooperation on intellectual property rights (IPR) protection and enforcement. The MOU was signed in an effort to create a…
-
By Christopher P. Singer — Within the last month, a number of foreign patent offices that act as International Searching Authorities (ISA) for the PCT announced fee increases to their search fees. IP Australia and the Korean Intellectual Property Office both enacted search fee increases that have been effective since September 15, 2009. The…
-
By Christopher P. Singer — Back on September 24, 2009, WIPO announced that Thailand deposited its instrument of accession to the Patent Cooperation Treaty (PCT), becoming the 142nd contracting state of the treaty. The current list of contracting states can be viewed here. The accession by Thailand means that in any international application filed…
-
By Donald Zuhn –- Last month, the international humanitarian aid organization Médecins Sans Frontières (MSF) — known to many as Doctors Without Borders — announced that it was asking nine of the world's largest pharmaceutical companies to pool their HIV patents in order to accelerate the availability of new treatments to HIV/AIDS patients. As…
-
By Donald Zuhn — The U.S. Patent and Trademark Office announced today that it had signed a Workplan for Bilateral Cooperation on intellectual property issues with the African Regional Intellectual Property Organization (ARIPO). The Workplan, which will serve to promote the development of effective intellectual property systems in ARIPO member countries, was signed by…
-
By Donald Zuhn — Last month, Alnylam Pharmaceuticals announced that it would contribute more than 1,500 of its RNA interference (RNAi) patents to the patent pool established by GlaxoSmithKline earlier this year. Alnylam is known for the development of therapeutics based on RNAi for the treatment of respiratory syncytial virus (RSV) infection, liver cancer,…
-
By Kevin E. Noonan — Venezuelan President Hugo Chavez (at right) made headlines last month, and caused not a small amount of consternation, with the pronouncement that his government would act to prevent foreign (read: Western or U.S.) drug companies from enforcing patents to maintain high drug prices in his country. However, according to…
-
By Kevin E. Noonan — A great deal has been written over the past week about Venezuela's new patented drug policy. Last Saturday, President Hugo Chavez (at right) announced that his government would "shake up" Venezuela's intellectual property laws, particularly with respect to patents on medicines. As reported by Reuters and the Associated Press,…
-
By Bradley Crawford — In the first post in this series, background information from Mr. Enrique Molina Galan's presentation at BIO 2009 was reported. The focus of this post is on the second part of his talk, where Mr. Molina Galan described the European Patent Office's role in fostering innovation. In his talk, Mr.…
-
By Ariadni Athanassiadis, Catherine Lemay, and Claire Palmer — In Canada, for subject matter to be patentable, it must be novel, inventive, and have utility. A patent will fail for lack of utility if it can be shown that "the invention will not work, either in the sense that it will not operate at all…
Patent Docs 